NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Hematological malignancies confirmed histologically:
- AML in morphological CR or not in morphological CR but not rapidly progressing (i.e. no need to give treatments such as hydroxyurea to maintain WBC count < 10 000 x109/mL);
- MDS;
- CML in CP or AP;
- MPD not in blast crisis,
- MDS/MPD overlap,
- ALL in CR;
- Multiple myeloma;
- CLL;
- Non-Hodgkin’s lymphoma (aggressive NHL should have chemosensitive disease);
- Hodgkin’s disease with chemosensitive disease or responding to checkpoint inhibitors.
1 total trials1 recruiting
Filter these 1 trials by phase, country, sponsor and more.